ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,994Medicare Part D Prescriptions Filled, Including Refills

Rank: 209 out of 1454

$817K Total Retail Price of All Prescriptions

Rank: 165 out of 1454

477 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 616 440 1 4
SIMVASTATIN 508 372 2 1
FUROSEMIDE 467 425 3 6
AMLODIPINE BESYLATE 445 343 4 2
OMEPRAZOLE 426 319 5 3
ATENOLOL 269 191 6 18
QUETIAPINE FUMARATE 256 172 7 91
DONEPEZIL HCL 244 232 8 29
LEVOTHYROXINE SODIUM 221 189 9 5
POTASSIUM CHLORIDE 208 158 10 15
METFORMIN HCL 204 125 11 8
ALLOPURINOL 196 183 12 28
NAMENDA 195 195 13 48
TAMSULOSIN HCL 191 141 14 34
DIOVAN 189 157 15 40
ATORVASTATIN CALCIUM 180 157 16 11
HYDROCHLOROTHIAZIDE 172 161 17 9
CRESTOR 171 145 18 22
RISPERIDONE 167 120 19 86
METOPROLOL TARTRATE 167 130 19 10
KLOR-CON M20 154 115 21 54
PAROXETINE HCL 150 136 22 73
GLIMEPIRIDE 135 135 23 33
NOVOLOG 132 117 24 99
CITALOPRAM HBR 120 108 25 21
METOPROLOL SUCCINATE 118 101 26 13
DIVALPROEX SODIUM 118 35 26 106
PRAVASTATIN SODIUM 117 96 28 12
SEROQUEL 116 87 29 177
MIRTAZAPINE 112 112 30 53
BENZTROPINE MESYLATE 112 35 R 30 174
LOSARTAN POTASSIUM 110 93 32 14
PHENYTOIN SODIUM EXTENDED 109 70 33 138
GLIPIZIDE 106 87 34 62
ACTOS 106 71 34 90
PANTOPRAZOLE SODIUM 104 104 36 31
WARFARIN SODIUM 98 98 37 17
RAMIPRIL 93 91 38 66
LANTUS 90 72 39 51
CARBAMAZEPINE 89 32 40 230
CLOPIDOGREL 86 72 41 32
TRIAMTERENE-HCTZ 85 74 42 44
RANITIDINE HCL 77 71 43 43
FLUPHENAZINE DECANOATE 77 11 43 417
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 72 45 27
DIGOXIN 71 71 46 70
ENALAPRIL MALEATE 71 58 46 58
PLAVIX 69 59 48 45
EXELON 68 68 49 135
AZITHROMYCIN 67 49 50 42
HYDROCODONE-ACETAMINOPHEN 65 61 S3 51 7
SERTRALINE HCL 65 20 51 26
CYMBALTA 61 57 53 55
TRAZODONE HCL 60 51 54 50
SPIRONOLACTONE 60 49 54 63
AMITRIPTYLINE HCL 59 31 R 56 71
ADVAIR DISKUS 58 53 57 47
HALOPERIDOL 58 24 57 220
GABAPENTIN 55 32 59 16
DOXAZOSIN MESYLATE 55 55 59 87
CARVEDILOL 53 49 61 24
LIPITOR 51 50 62 74
IBUPROFEN 50 32 63 107
PIOGLITAZONE HCL 50 37 R 63 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.